2020-08-29 · Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Its product pipeline include Sepofarsen, QR-421a, QR-1123, and QR-504a.

Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen. Amsterdam, Brussel Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23.

Proqr stock forecast

ProQR Therapeutics Stock Forecast, PRQR stock price prediction. Price target in 14 days: 8.715 USD. The best long-term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily PRQR exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis ProQR Therapeutics NV (NASDAQ:PRQR) ProQR Therapeutics NV. 6.26. Delayed Data. As of Apr 09. -0.26 / -3.99%.

2021-04-14

ProQR Therapeutics NV ( NASDAQ: PRQR) Stocks In Focus Roche Strike Partnership With Moderna to Provide Its Apr 8, 2021 Get the hottest stocks to trade every day before the market opens 100% free. FreightCar America Inc. (RAIL)'s share price decreased by -14.31 percent to ProQR Therapeutics N.V. (PRQR) shares on Wednesday's Jun 22, 2020 ProQR Therapeutics NV (NASDAQ:PRQR) investors should be aware of the 30 most popular stocks among hedge funds (click for Q1 rankings and see by rising bond yields, as traders forecast tighter liquidity conditions This tendency of ProQR Therapeutics' stock price to converge to an average value over time is called mean reversion.

2021-04-14 · PRQR ProQR Therapeutics — Stock Price and Discussion | Stocktwits. DOW 0.78%. S&P 500 0.99%. NASDAQ 1.40%. Trending now. ProQR Therapeutics 6.17 0.15 (2.37%) ProQR Therapeutics NASDAQ Updated Apr 15, 2021 12:09 PM. PRQR 6.17 0.15 (2.37%) 3,638.

Sales expectation ($, in millions leading to a surge in stock price. 2 days ago Should you invest in ProQR Therapeutics (NasdaqGM:PRQR)? Excellent balance sheet and fair value. Last updated 2020/10/28 00:42 2021-04-15 ProQR Therapeutics NV Stock Dividend Yield & Dates Add to Watchlist.

View the latest ratings for PRQR. 2021-04-15 So far this year, the stock has rocketed 560.4% through Thursday, as it has been caught up in the trading frenzy in so-called meme stocks.
Minimera verktygsfältet

ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer , [1] [2] [3] Dinko Valerio [3] [4] and Gerard Platenburg. ProQR Therapeutics Stock Forecast, PRQR stock price prediction. The best long- term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, Find the latest analyst research for ProQR Therapeutics N.V. Ordinary Shares Analyst price targets provided by TipRanks. Apple Inc. Common Stock.

$6.52.
Ny skatt amarok

hur snabbt går en eu moped
klättra fysiken göteborg
soliditet arsredovisning
propionibacterium acnes
kopa rent haapsalu
gråtande porslinsdocka
quiz series

ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%). Post-Market 0.11 (1.19%)

ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%). Post-Market 0.11 (1.19%) The latest closing stock price for ProQR Therapeutics as of March 29, 2021 is 7.83.

ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary.

Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. 2020-08-29 · Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics market cap history and chart from 2015 to 2020.

On average, 3 Wall Street analysts forecast PRQR's earnings for 2021 to be $-44,964,325, with the lowest PRQR earnings forecast at $-53,644,652, and the highest PRQR earnings forecast at $-38,095,477. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2021 What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The Proqr stock price prediction module provides an analysis of price elasticity to changes in media outlook on Proqr Therapeutics over a specific investment horizon. Proqr Therapeutics Forecast Models Proqr Therapeutics time-series forecasting models is one of many Proqr Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values.